Expression of the organic anion transporters OATP1B1, OATP1B3, and OATP2B1 in human liver is affected by genetic and nongenetic factors

被引:0
|
作者
Nies, A. [1 ]
Winter, S. [1 ]
Burk, O. [1 ]
Klein, K. [1 ]
Zanger, U. M. [1 ]
Stieger, B. [2 ]
Schwab, M. [1 ,3 ]
Schaeffeler, E. [1 ]
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[2] Univ Spital Zurich, Klin Klin Pharmakol & Toxikol, Zurich, Switzerland
[3] Univ Tubingen, Klin Pharmakol Abt, Tubingen, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:80 / 80
页数:1
相关论文
共 50 条
  • [41] 8-acetoxy-trisulfopyrene as the first activatable fluorogenic probe for add-and-read assessment of Organic anion-transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1
    Ungvari, Orsolya
    Kiraly, Laura
    Bakos, Eva
    Ozvegy-Laczka, Csilla
    FASEB JOURNAL, 2021, 35 (09):
  • [42] Nostocyclopeptide-M1: A Potent, Nontoxic Inhibitor of the Hepatocyte Drug Transporters OATP1B3 and OATP1B1
    Herfindal, Lars
    Myhren, Lene
    Kleppe, Rune
    Krakstad, Camilla
    Selheim, Frode
    Jokela, Jouni
    Sivonen, Kaarina
    Doskeland, Stein O.
    MOLECULAR PHARMACEUTICS, 2011, 8 (02) : 360 - 367
  • [43] Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3
    Gui, Chunshan
    Miao, Yi
    Thompson, Lucas
    Wahlgren, Bret
    Mock, Melissa
    Stieger, Bruno
    Hagenbuch, Bruno
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 584 (01) : 57 - 65
  • [44] Clinical Importance of OATP1B1 and OATP1B3 in Drug-Drug Interactions
    Shitara, Yoshihisa
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (03) : 220 - 227
  • [45] Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide
    Zimmerman, Eric I.
    Hu, Shuiying
    Roberts, Justin L.
    Gibson, Alice A.
    Orwick, Shelley J.
    Li, Lie
    Sparreboom, Alex
    Baker, Sharyn D.
    CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1458 - 1466
  • [46] The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3
    Seithel, Annick
    Eberl, Sonja
    Singer, Katrin
    Auge, Daniel
    Heinkele, Georg
    Wolf, Nadine B.
    Doerje, Frank
    Fromm, Martin F.
    Koenig, Joerg
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (05) : 779 - 786
  • [47] Development of a multiplex UPLC-MRM MS method for quantification of human membrane transport proteins OATP1B1, OATP1B3 and OATP2B1 in in vitro systems and tissues
    Ji, Chengjie
    Tschantz, William R.
    Pfeifer, Nathan D.
    Ullah, Mohammed
    Sadagopan, Nalini
    ANALYTICA CHIMICA ACTA, 2012, 717 : 67 - 76
  • [48] Comparison of human and rat drug transporter OATP2B1/Oatp2b1
    Hussner, J.
    Nageleisen, S.
    Seibert, I.
    zu Schwabedissen, H. Meyer
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S61 - S61
  • [49] Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3
    van de Steeg, E.
    Venhorst, J.
    Jansen, H. T.
    Nooijen, I. H. G.
    DeGroot, J.
    Wortelboer, H. M.
    Vlaming, M. L. H.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 : 29 - 36
  • [50] Transport by OATP1B1 and OATP1B3 enhances cytotoxicity of EGCG and certain substituted quercetins
    Zhang, Yuchen
    Hays, Amanda
    Noblett, Alexander
    Thapa, Mahendra
    Hua, Duy H.
    Hagenbuch, Bruno
    FASEB JOURNAL, 2013, 27